Updates are available Correction dated 2019-06-11
Click to view Correction: https://doi.org/10.1038/s41398-019-0501-y
Updates are available Correction dated 2018-08-31
Click to view Correction: https://doi.org/10.1038/s41398-018-0187-6
-
Authors
Jauhar, S
Veronese, M
Rogdaki, M
Bloomfield, M
Natesan, S
Turkheimer, F
Kapur, S
Howes, O D
- License Information
-
More Information
Article History
Received: 22 February 2016
Revised: 25 July 2016
Accepted: 2 August 2016
First Online: 7 February 2017
Change Date: 31 August 2018
Change Type: Correction
Change Details: This Article was originally published under a CC BY-NC-SA 4.0 license, but has now been made available under a CC BY 4.0 license. The PDF and HTML versions of the Article have been modified accordingly.
Change Date: 11 June 2019
Change Type: Correction
Change Details: "An amendment to this paper has been published and can be accessed via a link at the top of the paper."
Competing interests
: ODH has received speaker bureau honoraria and charitable reseach funding from AstraZeneca, BMS, Eli Lilly, Jansenn-Cilag and Roche. The work of ODH has been funded by the Medical Research Council, UK and Wellcome Trust. SK has received grant support from AstraZeneca and GlaxoSmithKline and has served as consultant and/or speaker for AstraZeneca, Bioline, BMS-Otsuka, Eli Lilly, Janssen (J&J), Lundbeck, NeuroSearch, Pfizer, Roche, Servier and Solvay Wyeth. The remaining authors declare no conflict of interest.
